Point of Care Nano Technology : 1st Quarter Report 2022

			POINT OF CARE NANO-TECHNOLOGY, INC.
	INTERIM STATEMENTS OF STOCKHOLDERS' DEFICIT
											(Unaudited)
			For the three month period ended October 31, 2021
			Preferred stock					Common stock	Accumulated	Stockholders'
		Shares	Amount			Shares			Amount		Paid-in Capital		Deficit		Deficit
Balance, July 31, 2021		-		$		-			$	46,981,059			$	4,698			$	120,187,429			$	(120,212,367	)	$	(20,240)
	Shares issued		1,000				1				-				-				-				-			1
	Net loss for the period		-				-				-				-				-				(42,255	)		(42,255)
	Balance, Oct 31, 2021		1,000				1				46,981,059				4,698				120,187,429				(120,254,622	)	$	(62,494
			For the three month period ended October 31, 2020
											Common stock	Accumulated	Stockholders'
											Shares			Amount		Paid-in Capital		Deficit			Deficit

Balance, July 31, 2020 Net loss for the period

Balance, Oct 31, 2020

$46,981,059	$	4,698	$	120,187,429	$(120,204,867)	$	(12,740)
-		-		-	-		-
$46,981,059	$	4,698	$	120,187,429	$(120,204,867) $	(12,740)

F-16

	POINT OF CARE NANO-TECHNOLOGY, INC.
	INTERIM STATEMENTS OF CASH FLOWS
		(Unaudited)
					For the three		For the three
					months ended		months ended
				October 31,2021	October 31, 2020
Cash flows from operating activities
Net loss for the period			$	(42,255)		$	-
	Non-cash expense
	Officer compensation				1			-
	Change in operating assets and liabilities
	Accounts payable and accrued charges				42,254			-
Net cash flows from operating activities				-			-
Net cash flows from investing activities				-			-

	Net cash flows from financing activities				-			-
Change in cash for the period				-			-
Cash, beginning of period				-			-
Cash, end of period				-			-
Supplemental Disclosures of Cash Flow information
Cash paid during the period for:
	Interest			$	0.00		$	0.00
	Income taxes			$	0.00		$	0.00
		F-17

POINT OF CARE NANO-TECHNOLOGY, INC.

NOTES TO THE INTERIM FINANCIAL STATEMENTS

OCTOBER 31, 2021

Note 1 COMPANY AND BACKGROUND

Point of Care Nano-Technology, Inc. (the "Company") was incorporated under the laws of the State of Nevada on June 10, 2010, under the name of "Alternative Energy and Environmental Solutions, Inc." On August 28, 2014, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to "Unique Growing Solutions, Inc." On March 31, 2015, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to "Point of Care Nano-Technology, Inc."

Since February 26, 2015, the Company's business model has related to using its license from Lamina Equities Corporation to first develop and then manufacture saliva-based medical diagnosis products.

The Company had been engaged in the various business since its incorporation. The Company was not successful and discontinued the majority of its operation by July 31, 2016. Beginning from August 2016, the Company plans on providing business services and financing to emerging growth entities. The Company's plan of operation over the next 12 months is to seek new business assets in the life sciences industry. The Company cannot make any guarantee that it will be successful in achieving this goal.

On April 15, 2021, the Company accepted the resignations of Dr. Guirguis and Mr. El-Salhy, received a mutual release from both, and appointed Mr. Nicholas DeVito to be Director, Chief Executive Officer and Chief Financial Officer. In addition, Mr. DeVito was awarded 1,000 shares of Class A Preferred Stock that grants him 80% voting rights.

Also on April 15, 2021 the Company agreed to form a subsidiary and transfer all debts and the License agreement back to Dr. Guirguis in exchange for 26,000,000 shares of Common Stock. This transaction was not closed by July 31, 2021.

The Company's principal executive office location and mailing address is 109 Ambersweet Way, Davenport, FL 33897 and its telephone number is 732-723-7395.

These interim financial statements have been prepared in accordance with generally accepted principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations

for its next twelve months. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classifications of assets and liabilities should the Company be unable to continue as a going concern. At October 31, 2021, the Company had not yet achieved profitable operations and had accumulated losses of $120,254,622 since its inception, all of which casts substantial doubt about the Company's ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due.

Note 2 CONTROL BY PRINCIPAL OWNERS

The directors and executive officers own, directly or indirectly, beneficially and in the aggregate, the majority of the voting power of the outstanding capital of the Company. Accordingly, directors, executive officers and their affiliates, if they voted their shares uniformly, would have the ability to control the approval of most corporate actions, including approving significant expenses, increasing the authorized capital and the dissolution, merger, or sale of the Company's assets.

F-18

Note 3 ACCOUNTING POLICIES

Basis of Presentation

While the information presented is unaudited, it includes all adjustments, which are, in our opinion of management, necessary to present fairly the financial position, result of operations and cashflows for the interim period presented in accordance with accounting principles generally accepted in the United States of America. All adjustments are of a normal recurring nature. These interim financial statements should be read in conjunction with the Company's July 31, 2021 annual financial statements. Operating results for the three months ended October 31, 2021 are not necessarily indicative of the results that can be expected for the period ended July 31, 2022.

Significant Accounting Policies

There have been no material changes in the Company's significant accounting policies to those previously disclosed in the July 31, 2021 annual report.

Use of estimates

The preparation of the consolidated interim financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes its best estimate of the ultimate outcome for these items based on historical trends and other information available when the financial statements are prepared. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates.

Recent Accounting Pronouncements

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company's results of operations, financial position, or cash flow.

Note 4 COMMON and PREFERRED STOCK

The Company has authorized capital of 75,000,000 shares of common stock and 25,000,000 shares of "blank check" preferred stock, each with a par value of $0.001.

On August 2, 2021, the Company issued 1,000 preferred shares for officer compensation valued at $1.

There were no warrants or options outstanding as of October 31, 2021.

Note 5 Subsequent Events

None